Radnor Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.39M | Sell |
6,596
-4
| -0.1% | -$1.37K | 0.34% | 79 |
|
|
2026
Q1 | $2.32M | Sell |
6,600
-256
| -4% | -$91.3K | 0.34% | 72 |
|
|
2025
Q4 | $2.24M | Buy |
6,856
+407
| +6% | +$129K | 0.33% | 86 |
|
|
2025
Q3 | $1.82M | Sell |
6,449
-420
| -6% | -$122K | 0.28% | 100 |
|
|
2025
Q2 | $1.92M | Hold |
6,869
| – | – | 0.31% | 91 |
|
|
2025
Q1 | $2.14M | Sell |
6,869
-166
| -2% | -$49K | 0.36% | 73 |
|
|
2024
Q4 | $1.83M | Sell |
7,035
-460
| -6% | -$136K | 0.31% | 87 |
|
|
2024
Q3 | $2.42M | Buy |
7,495
+460
| +7% | +$150K | 0.36% | 70 |
|
|
2024
Q2 | $2.2M | Buy |
7,035
+75
| +1% | +$22K | 0.67% | 33 |
|
|
2024
Q1 | $1.98M | Hold |
6,960
| – | – | 0.34% | 77 |
|
|
2023
Q4 | $2M | Buy |
6,960
+60
| +0.9% | +$16.3K | 0.37% | 70 |
|
|
2023
Q3 | $1.85M | Buy |
+6,900
| New | +$1.72M | 0.37% | 77 |
|
|
2023
Q2 | – | Sell |
-8,000
| Closed | -$1.93M | – | 135 |
|
|
2023
Q1 | $1.93M | Buy |
8,000
+190
| +2% | +$46.6K | 0.51% | 54 |
|
|
2022
Q4 | $2.13M | Buy |
7,810
+780
| +11% | +$209K | 0.52% | 51 |
|
|
2022
Q3 | $1.58M | Buy |
7,030
+733
| +12% | +$178K | 0.46% | 58 |
|
|
2022
Q2 | $1.53M | Buy |
6,297
+60
| +1% | +$14.7K | 0.42% | 72 |
|
|
2022
Q1 | $1.51M | Sell |
6,237
-75
| -1% | -$17.2K | 0.38% | 80 |
|
|
2021
Q4 | $1.42M | Buy |
+6,312
| New | +$1.33M | 0.35% | 75 |
|
|
2021
Q3 | – | Sell |
-2,207
| Closed | -$538K | – | 103 |
|
|
2021
Q2 | $538K | Hold |
2,207
| – | – | 0.18% | 108 |
|
|
2021
Q1 | $549K | Hold |
2,207
| – | – | 0.18% | 124 |
|
|
2020
Q4 | $507K | Buy |
2,207
+25
| +1% | +$5.76K | 0.14% | 128 |
|
|
2020
Q3 | $555K | Buy |
2,182
+190
| +10% | +$47.1K | 0.19% | 108 |
|
|
2020
Q2 | $508K | Hold |
1,992
| – | – | 0.18% | 112 |
|
|
2020
Q1 | $404K | Hold |
1,992
| – | – | 0.17% | 109 |
|
|
2019
Q4 | $480K | Hold |
1,992
| – | – | 0.15% | 116 |
|
|
2019
Q3 | $385K | Hold |
1,992
| – | – | 0.13% | 127 |
|
|
2019
Q2 | $367K | Buy |
1,992
+25
| +1% | +$4.48K | 0.12% | 124 |
|
|
2019
Q1 | $374K | Hold |
1,967
| – | – | 0.12% | 134 |
|
|
2018
Q4 | $383K | Hold |
1,967
| – | – | 0.14% | 131 |
|
|
2018
Q3 | $408K | Hold |
1,967
| – | – | 0.13% | 138 |
|
|
2018
Q2 | $363K | Hold |
1,967
| – | – | 0.13% | 142 |
|
|
2018
Q1 | $335K | Hold |
1,967
| – | – | 0.11% | 150 |
|
|
2017
Q4 | $342K | Hold |
1,967
| – | – | 0.11% | 148 |
|
|
2017
Q3 | $339K | Hold |
1,967
| – | – | 0.11% | 147 |
|
|
2017
Q2 | $339K | Hold |
1,967
| – | – | 0.11% | 147 |
|
|
2017
Q1 | $323K | Hold |
1,967
| – | – | 0.11% | 147 |
|
|
2016
Q4 | $288K | Buy |
+1,967
| New | +$296K | 0.1% | 153 |
|
Other funds holding AMGN
FFM
SP
Radnor Capital Management's AMGN Position: Q2 2026 in Review
Radnor Capital Management reduced its Amgen (AMGN) stake by 0.06% in Q2 2026, selling an estimated $1.37K and leaving 6,596 shares worth $2.39M. The position accounts for 0.34% of the portfolio, ranked #79.
Radnor Capital Management first reported a position in AMGN in Q4 2016 and has held it in 37 quarters since. The position peaked at $2.42M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Radnor Capital Management held 6,596 shares of Amgen worth $2.39M as of Q2 2026.
- Radnor Capital Management sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
- Amgen made up 0.34% of Radnor Capital Management's portfolio in Q2 2026, its #79 holding.
- Radnor Capital Management first reported a position in Amgen in Q4 2016 and has held it in 37 quarters since.
- Radnor Capital Management's Amgen position peaked at $2.42M in Q3 2024.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.